Matches in Wikidata for { <http://www.wikidata.org/entity/Q64636305> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q64636305 description "clinical trial" @default.
- Q64636305 description "ensayu clínicu" @default.
- Q64636305 description "klinisch onderzoek" @default.
- Q64636305 description "клінічне випробування" @default.
- Q64636305 name "VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Everolimus for Treating Patients With Pancreatic Neuroendocrine Tumors" @default.
- Q64636305 type Item @default.
- Q64636305 label "VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Everolimus for Treating Patients With Pancreatic Neuroendocrine Tumors" @default.
- Q64636305 prefLabel "VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Everolimus for Treating Patients With Pancreatic Neuroendocrine Tumors" @default.
- Q64636305 P1050 Q64636305-BABA295D-D32D-458B-B682-43A47F448D42 @default.
- Q64636305 P1132 Q64636305-937DFE01-A3EB-4473-B838-64C175619CC8 @default.
- Q64636305 P1476 Q64636305-8E75E575-DCAA-4EAC-BF4B-935E3BA8A024 @default.
- Q64636305 P17 Q64636305-F84503D2-82D7-4F84-929C-FF272E9E82F4 @default.
- Q64636305 P2899 Q64636305-C9A1357F-C624-48CF-AAD0-ACDFBB4E8153 @default.
- Q64636305 P3098 Q64636305-91C8BF7C-EA62-448C-9C9A-366150A4A2B0 @default.
- Q64636305 P31 Q64636305-4209CE04-C911-44FD-9066-765A5BDE4896 @default.
- Q64636305 P4844 Q64636305-9ADD39A8-D10B-4A15-8867-41376EFBC32B @default.
- Q64636305 P580 Q64636305-1F641585-7917-4098-A356-62D21660FF5B @default.
- Q64636305 P582 Q64636305-FCE5D7C5-C258-4DA9-A1F5-4BFC0984E17A @default.
- Q64636305 P6099 Q64636305-06350FAE-3B6D-44C3-825D-3D39139DD60C @default.
- Q64636305 P6099 Q64636305-F763B7FB-EA5F-4384-9655-B4439590BB27 @default.
- Q64636305 P6153 Q64636305-0A48B1E5-D75D-47FE-BF60-225064277D8E @default.
- Q64636305 P6153 Q64636305-B281E4A6-1F65-4EC2-B9FB-2694D59BA0B4 @default.
- Q64636305 P8363 Q64636305-521EBC3C-743E-4305-90AA-A4147CE04B4F @default.
- Q64636305 P1050 Q356033 @default.
- Q64636305 P1132 "+23" @default.
- Q64636305 P1476 "A Phase I/II Study of X-82, an Oral Anti-VEGFR Tyrosine Kinase Inhibitor, With Everolimus for Patients With Pancreatic Neuroendocrine Tumors" @default.
- Q64636305 P17 Q30 @default.
- Q64636305 P2899 "+18" @default.
- Q64636305 P3098 "NCT01784861" @default.
- Q64636305 P31 Q30612 @default.
- Q64636305 P4844 Q32089 @default.
- Q64636305 P580 "2013-05-03T00:00:00Z" @default.
- Q64636305 P582 "2019-06-30T00:00:00Z" @default.
- Q64636305 P6099 Q42824440 @default.
- Q64636305 P6099 Q5452194 @default.
- Q64636305 P6153 Q29052 @default.
- Q64636305 P6153 Q7972509 @default.
- Q64636305 P8363 Q78089383 @default.